Magnetic Resonance Spectroscopy
10
5
5
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (10)
MRI Biomarkers Predictive of Disability Progression in Patients With Multiple Sclerosis
Non-Invasive Monitoring Of Metabolite Levels Using Novel And Adapted MR Spectroscopy Techniques
ETASCAN Project: ETAS Project 2
Magnetic Resonance & Optical Spectroscopy Validation
Effects of tDCS for Enhancing Cognitive Function in Individuals With Persistent Post-Concussion Syndrome
New Imaging Biomarkers Predictive of MA Progression
Investigating Myosteatosis in Steatotic Liver Diseases
Study of Phosphorylated Metabolism Profile as Predictive Biomarker of Cognitive Decline in Memory Complaint.
Optimising the Duration of Cooling in Mild Encephalopathy
Pathophysiological Understanding and Treatment of PTSD: an rTMS Approach